Liang Kong



Liang Kong enrolled in the prestigious China Pharmaceutical University in 1997, where he majored in international pharmaceutical trade. He subsequently continued graduate study of pharmaceutical administration, and was appointed a research executive from 2001 to 2003 at China ’s Nanjiing Yaxing Marketing Research Company, which specializes in pharmaceuticals. Subsequently, he was appointed to be a sales manager of a pharmaceutical company from 2003 to 2004. From 2004 to 2007, he was assigned as a project manager for clinical trials in China or the other Asian countries.

Mr.
Kong has a deep understanding of China pharmaceutical market and regulations, and has supplied service for many China and international pharmaceutical companies. He has a wide connection with China pharmaceutical industry. He has provided a lot of presentations on China market and regulation in all kinds of conference and published a lot of reports regarding China pharmaceutical industry.

Mr. Kong has published articles in the journals China Pharmaceuticals and China Pharmacy, as well as acting as correspondent to international pharmaceutical publications, and also consultant to some international pharmaceutical companies.

 

List of reports from Liang Kong

Drug Registration In China An overview of China Drug Registration Procedures
12/1/2009 | published by: Liang Kong
... API, checimical finished product, biological product, and Traditional Chinese Medicine, and medicinal Instrument) in China was around USD 100 billion, and the chemical finished product market size was around USD 30 billion. China pharmaceutical regulations ...  |  more...
$1,400.00
How To Conduct Clinical Trials In China
2/1/2009 | published by: Liang Kong
... of amendment has already been put into public for comments. It was noted that a lot of medicine/pharmaceutical patent related articles were added in the draft version, such as genetic resources, medicines compulsory licensing, parallel ...  |  more...
$850.00
China HealthCare & Pricing System Reform 2008
11/10/2008 | published by: Liang Kong
... than 15% every year. So no one can neglect the huge potential of China with its pharmaceutical market that is expanding greatly day by day. China pharmaceutical pricing and reimbursement is a complex and ever-changing ...  |  more...
$1,200.00
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!